Bevacizumab-Induced Reversible Thrombocytopenia in a Patient with Adenocarcinoma of Colon: Rare Adverse Effect of Bevacizumab

Figure 1

Changes in platelet count in relation to treatment with Bevacizumab. Arrows indicate injection of bevacizumab (5 mg/kg).